Ibogaine List Archives – 2003-02

MindVox Corporation

From: MARC <marc420emery@shaw.ca> Subject: Re: [ibogaine] Stuart Date: February 28, 2003 at 2:03:13 PM EST To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com That was very interesting information indeed! Does Carl N.W. still work with iboga? I understand Carl is Sara Glatt’s husband? Does he still make written contributions on his experiences? I know…

Continue reading

Ibogaine List Archives – 2002-12

Clear Sky Recovery

From: Ustanova Iboga <Iboga@guest.arnes.si> Subject: [ibogaine] best wishes Date: December 31, 2002 at 8:06:10 PM EST To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com Hi everybody, we are in 2003 already, and americans are a year behind… Ha ha ha ha!!! Anyway, I wish everyone reading this an IBOgainised 2003! ;-)) Marko From: Gamma…

Continue reading

Ibogaine List Archives – 2002-11

Clear Sky Recovery

From: Brett Calabrese <bcalabrese@yahoo.com> Subject: Re: [ibogaine] (still OT) Re: [ibogaine] (OT) Re:don’t mature right? Date: November 30, 2002 at 5:32:34 PM EST To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com Preston, Sorry for the post, you missed my point entirely. A couple comments; Yes I am feeling just fine, no I am not…

Continue reading

Ibogaine List Archives – 2002-10

Clear Sky Recovery

From: Dana Beal <dana@cures-not-wars.org> Subject: [ibogaine] Given pot laws, how honest are feds? Date: October 31, 2002 at 11:02:46 PM EST To: philipkdick@yahoogroups.com Cc: dansmith@clark.net, lensman@stardrive.org, hward@wineshopper.com, Mark@k-dunn.freeserve.co.uk, IMDJam@cs.com, gbekkum@mediaone.net, Gary@osborn-day.freeserve.co.uk, gschwart@u.arizona.edu, e-merrill2@ti.com, “Bob Ezergailis” <morpheal@bserv.com>, “cynthia ford” <maruta@wco.com>, “G. G. Ford” <swimp@shaw.ca>, <brumac@compuserve.com>, <yokatta@oxy.edu>, <kklingon@cwcom.net>, <cyrano@aqua.ocn.ne.jp>, “Adrian” <afme@ihug.co.nz>, dewatson@sunflower.com,…

Continue reading

A Psychedelic Trip to the End of Addiction

Copyright 1993 Newsweek Newsweek August 23, 1993 , UNITED STATES EDITION LANGUAGE: ENGLISH LOAD-DATE-MDC: August 25, 1993 SECTION: LIFE/STYLE; Health; Pg. 45 LENGTH: 601 words HEADLINE: A Psychedelic Trip to the End of Addiction BYLINE: GEOFFREY COWLEY with HEATHER HEIMAN and JOSHUA COOPER RAMO HIGHLIGHT: Can a tribal potion block…

Continue reading

The Ibogaine Connection (Day One – ABC)

Copyright 1993 American Broadcasting Companies, Inc. All rights reserved ABC NEWS SHOW: Day One (ABC 8:00 pm ET) August 30, 1993 Transcript # 126-4 LANGUAGE: ENGLISH LOAD-DATE-MDC: December 21, 1993 TYPE: Package SECTION: News LENGTH: 2811 words HEADLINE: The Ibogaine Connection HIGHLIGHT: Ibogaine is a psychedelic drug derived from the…

Continue reading

The mystery of ibogaine: can an African psychedelic cure addiction?

Copyright Omni Publications International Ltd. 1993 Omni July, 1993 SECTION: Vol. 15 ; No. 9 ; Pg. 14; ISSN: 0149-8711 LENGTH: 757 words HEADLINE: The mystery of ibogaine: can an African psychedelic cure addiction? BYLINE: Nadis, Steve BODY: Wild claims have been made about ibogaine, an hallucinogenic substance derived from…

Continue reading

Addiction and Obsession

Copyright 1992 Newsday, Inc. Newsday November 19, 1992, Thursday, NASSAU AND SUFFOLK EDITION SECTION: PART II; ADDICTION & OBSESSION; Pg. 68 Other Edition: City Pg. 72 LENGTH: 4505 words HEADLINE: Howard Lotsof insists he has the cure for drug addiction. Some authorities are beginning to take him seriously. BYLINE: By…

Continue reading

Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…

Continue reading

Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…

Continue reading